Julie G. Allickson, PhD, serves as the Chief Technology Officer at the Mayo Clinic's Center for Regenerative Medicine, where they lead technological innovations and external collaborations. With over 27 years of experience in clinical translation of cellular therapies, they previously held executive roles at Cryo-Cell International, Inc., and the Wake Forest Institute for Regenerative Medicine. Dr. Allickson's expertise spans research and development, project management, and regulatory compliance, contributing to advancements in tissue-engineered products and regenerative therapeutics. They are currently an Associate Professor of Regenerative Medicine at the Mayo Clinic and remain engaged in pioneering early-phase clinical trials. Dr. Allickson has completed both a Bachelor of Science and a Master of Science in Medical Laboratory Sciences from Florida International University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices